Darya-Varia Laboratoria Tbk (DVLA) - Total Liabilities
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has total liabilities worth Rp904.97 Billion IDR (≈ $53.03 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Darya-Varia Laboratoria Tbk (DVLA) net asset momentum to track the company's year-over-year net asset growth rate.
Darya-Varia Laboratoria Tbk - Total Liabilities Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's total liabilities have evolved over time, based on quarterly financial data. See DVLA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Darya-Varia Laboratoria Tbk Competitors by Total Liabilities
The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Maywood Acquisition Corp. 2 Class A Ordinary Share
NASDAQ:MYX
|
USA | $165.57K |
|
Dhampur Sugar Mills Limited
NSE:DHAMPURSUG
|
India | Rs12.17 Billion |
|
Renascor Resources Ltd
AU:RNU
|
Australia | AU$3.83 Million |
|
Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama AS
IS:INTEM
|
Turkey | TL2.58 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩98.92 Billion |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
USA | $28.62 Million |
|
Golf & Co Group Ltd
TA:GOLF
|
Israel | ILA864.76 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Darya-Varia Laboratoria Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Darya-Varia Laboratoria Tbk.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Darya-Varia Laboratoria Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual total liabilities of Darya-Varia Laboratoria Tbk from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp712.57 Billion ≈ $41.75 Million |
+11.73% |
| 2023-12-31 | Rp637.74 Billion ≈ $37.37 Million |
+5.32% |
| 2022-12-31 | Rp605.52 Billion ≈ $35.48 Million |
-14.12% |
| 2021-12-31 | Rp705.11 Billion ≈ $41.32 Million |
+6.77% |
| 2020-12-31 | Rp660.42 Billion ≈ $38.70 Million |
+26.06% |
| 2019-12-31 | Rp523.88 Billion ≈ $30.70 Million |
+8.56% |
| 2018-12-31 | Rp482.56 Billion ≈ $28.28 Million |
-8.01% |
| 2017-12-31 | Rp524.59 Billion ≈ $30.74 Million |
+16.11% |
| 2016-12-31 | Rp451.79 Billion ≈ $26.47 Million |
+12.17% |
| 2015-12-31 | Rp402.76 Billion ≈ $23.60 Million |
+47.09% |
| 2014-12-31 | Rp273.82 Billion ≈ $16.04 Million |
-0.56% |
| 2013-12-31 | Rp275.35 Billion ≈ $16.13 Million |
+18.10% |
| 2012-12-31 | Rp233.14 Billion ≈ $13.66 Million |
+16.36% |
| 2011-12-31 | Rp200.37 Billion ≈ $11.74 Million |
-6.15% |
| 2010-12-31 | Rp213.51 Billion ≈ $12.51 Million |
-6.64% |
| 2009-12-31 | Rp228.69 Billion ≈ $13.40 Million |
+76.17% |
| 2008-12-31 | Rp129.81 Billion ≈ $7.61 Million |
+31.52% |
| 2007-12-31 | Rp98.70 Billion ≈ $5.78 Million |
-31.94% |
| 2006-12-31 | Rp145.03 Billion ≈ $8.50 Million |
-9.37% |
| 2005-12-31 | Rp160.03 Billion ≈ $9.38 Million |
+42.69% |
| 2004-12-31 | Rp112.15 Billion ≈ $6.57 Million |
+12.06% |
| 2003-12-31 | Rp100.08 Billion ≈ $5.86 Million |
+4.43% |
| 2002-12-31 | Rp95.84 Billion ≈ $5.62 Million |
-55.81% |
| 2001-12-31 | Rp216.89 Billion ≈ $12.71 Million |
+5.23% |
| 2000-12-31 | Rp206.10 Billion ≈ $12.08 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more